Oral insulin Archives

Novo Nordisk targets bigger slice of diabetes market with new tablet

Analysts, Approvals, Biologicals, Blockbusters, Blood Sugar Levels, Business, Diabetes, FDA, First-of-its kind, Future Blockbusters, Glucagon-Like Peptide-1 (GLP-1) Analogs, Oral insulin, Pills, Weight

Danish drugmaker Novo Nordisk is aiming for a big slice of the multibillion-dollar diabetes market with a new pill approved by U.S. authorities that caters for patients with an aversion to needles.

FDA approves Novo Nordisk’s oral diabetes drug

Approvals, FDA, FDA/Regulatory, Glucagon-Like Peptide-1 (GLP-1) Analogs, Oral insulin, Pills, Type 2 Diabetes

The U.S. Food and Drug Administration approved Novo Nordisk’s Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with diet and exercise may improve blood sugar.

Novo Nordisk submits diabetes pill for U.S. approval

Cardiovascular, Chronic Kidney Disease, FDA, FDA/Regulatory, Glucagon-Like Peptide-1 (GLP-1) Analogs, Injections, New Drug Application (NDA), Non-alcoholic steatohepatitis (NASH), Obesity, Oral insulin, Pills, Type 2 Diabetes

Novo Nordisk submitted the company’s oral semaglutide drug, a pill that management hopes will transform the diabetes market, for approval in the United States.